Enzymology of Purine and Pyrimidine Antimetabolites Used in the Treatment of Cancer
Энзимология пуриновых и пиримидиновых антиметаболитов, применяемых для лечения рака
2009-05-29
SCID: 54.1/kzbsvdtm
Discuss with AI
E. coli PNP gene therapycancer treatmentenzymologypurine antimetabolitespyrimidine antimetabolites
Figures from the paper
Abstract (AI)
ADVERTISEMENT RETURN TO ISSUEPREVReviewNEXTEnzymology of Purine and Pyrimidine Antimetabolites Used in the Treatment of CancerWilliam B. Parker*†View Author Information Southern Research Institute, 2000 Ninth Avenue, South Birmingham, Alabama 35205* E-mail: [email protected]. Tel.: 205-581-2797. Fax: 205-581-2447.†Disclosure: Dr. Parker has a financial interest in clofarabine, thio-araC, and the E. coli PNP gene therapy strategy for the treatment of cancer.Cite this: Chem. Rev. 2009, 109, 7, 2880–2893Publication Date (Web):May 29, 2009Publication History Received23 January 2009Published online29 May 2009Published inissue 8 July 2009https://doi.org/10.1021/cr900028pCopyright © 2009 American Chemical SocietyRequest reuse permissionsArticle Views5730Altmetric-Citations426LEARN ABOUT THESE METRICSArticle Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated. Share Add toView InAdd Full Text with ReferenceAdd Description ExportRISCitationCitation and abstractCitation and referencesMore Options Share onFacebookTwitterWechatLinked InReddit Read OnlinePDF (1 MB) Get e-AlertscloseSUBJECTS:Cells,Genetics,Inhibition,Nucleic acids,Peptides and proteins Get e-Alerts
Key Findings
1
It focuses on how drug-metabolizing enzymes influence the efficacy and toxicity of clinically used antimetabolites.
2
The article discusses enzyme-targeted strategies, including clofarabine, thio-araC, and E. coli purine nucleoside phosphorylase gene therapy.
3
The review examines enzymatic mechanisms governing the activation, metabolism, and anticancer effects of purine and pyrimidine antimetabolites.
4
The review highlights enzymology as a basis for improving antimetabolite treatment strategies and developing cancer-selective therapies.
Research Object
Purine and pyrimidine antimetabolites used in cancer treatment
Research Subject
The enzymology of these antimetabolites, including their metabolic activation, enzymatic targets, and mechanisms of anticancer action
Publication Details
Publication Date
2009-05-29
Journal
Publisher
ISSN
Cited by
623
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest